Non-alcoholic fatty liver disease in diabetics - prevalence and predictive factors in a multiracial hospital clinic population in Malaysia

被引:58
|
作者
Chan, Wah-Kheong [1 ]
Tan, Alexander Tong-Boon [2 ]
Vethakkan, Shireene Ratna [2 ]
Tah, Pei-Chien [3 ]
Vijayananthan, Anushya [4 ]
Goh, Khean-Lee [1 ]
机构
[1] Univ Malaya, Fac Med, Gastroenterol & Hepatol Unit, Gastrointestinal Endoscopy Unit,Dept Med, Kuala Lumpur 50603, Malaysia
[2] Univ Malaya, Fac Med, Dept Med, Endocrinol Unit, Kuala Lumpur 50603, Malaysia
[3] Univ Malaya, Fac Med, Dept Biomed Imaging, Kuala Lumpur 50603, Malaysia
[4] Univ Malaya, Med Ctr, Dept Dietet, Kuala Lumpur 50603, Malaysia
关键词
diabetes mellitus; dietary intake; epidemiology; ethnicity; non-alcoholic fatty liver disease; physical activity; METABOLIC SYNDROME; CIRRHOSIS; NAFLD; EPIDEMIOLOGY; VARIABILITY; DIAGNOSIS; FIBROSIS;
D O I
10.1111/jgh.12204
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aim: There is currently no published study comparing prevalence of non-alcoholic fatty liver disease (NAFLD) and associated factors among diabetics of different ethnicity in the Asia-Pacific region. Methods: Cross-sectional study of consecutive patients in the Diabetic Clinic in University of Malaya Medical Centre. The Global Physical Activity Questionnaire and a semi-quantitative food-frequency questionnaire were used to assess physical activity and dietary intake, respectively. Diagnosis of NAFLD was ultrasound-based and following exclusion of significant alcohol intake. Results: Data for 399 patients were analyzed (mean age 62.3 +/- 10.5 years, 43.1% men). The racial distribution was Chinese 43.6%, Indian 33.1%, Malay 22.3%, and others 1.0%. The prevalence of NAFLD was 49.6%. On univariate analysis, factors associated with NAFLD were age < 65 years, race, obesity, central obesity, glycated hemoglobin >= 7.0%, and elevated serum alanine aminotransferase (ALT) and gamma-glutamyl transpeptidase levels. Patients with low physical activity were more likely to have NAFLD (odds ratio [OR] = 1.67, 95% confidence interval [CI] = 1.06-2.63, P = 0.020). The prevalence of NAFLD was highest among Malays (60.7%), followed by Indians (51.5%), and lowest among Chinese (42.0%) consistent with higher prevalence of central obesity and higher percentage calorie intake from fat in the former groups of patients. On multivariate analysis, independent factors associated with NAFLD were central obesity (OR = 2.20, 95% CI = 1.29-3.75, P = 0.004) and elevated serum ALT level (OR = 1.98, 95% CI = 1.21-3.25, P = 0.007). Conclusions: NAFLD was seen in half of a cohort of diabetic patients and was independently associated with central obesity and elevated serum ALT level. Prevalence of NAFLD was different and paralleled the difference in prevalence of central obesity and in percentage calorie intake from fat among the different ethnic groups.
引用
收藏
页码:1375 / 1383
页数:9
相关论文
共 50 条
  • [41] Managing non-alcoholic fatty liver disease
    Ngu, Jing Hieng
    Goh, George Boon Bee
    Poh, Zhongxian
    Soetikno, Roy
    SINGAPORE MEDICAL JOURNAL, 2016, 57 (07) : 368 - 370
  • [42] Elevated serum ferritin in non-alcoholic fatty liver disease is not predictive of fibrosis
    Trasolini, Roberto
    Cox, Ben
    Galts, Ciaran
    Yoshida, Eric M.
    Marquez, Vladimir
    CANADIAN LIVER JOURNAL, 2022, 5 (02): : 152 - 159
  • [43] Epidemiology and natural history of non-alcoholic fatty liver disease
    Fazel, Yousef
    Koenig, Aaron B.
    Sayiner, Mehmet
    Goodman, Zachary D.
    Younossi, Zobair M.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2016, 65 (08): : 1017 - 1025
  • [44] Global research trends in non-alcoholic fatty liver disease
    Putri, Wahyu Aristyaning
    Setiawan, Jajar
    Sofyantoro, Fajar
    Priyono, Dwi Sendi
    Septriani, Nur Indah
    Mafiroh, Wulan Usfi
    Yano, Yoshihiko
    Wasityastuti, Widya
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2023, 124 (08): : 590 - 598
  • [45] Non-alcoholic fatty Liver disease
    Calderaro, Julien
    Zafrani, Elie Serge
    ANNALES DE PATHOLOGIE, 2010, 30 (06) : 413 - 420
  • [46] Non-alcoholic fatty liver disease
    Smith, Briohny W.
    Adams, Leon A.
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2011, 48 (03) : 97 - 113
  • [47] Non-alcoholic fatty liver disease
    Li, Wenhao
    Alazawi, William
    CLINICAL MEDICINE, 2020, 20 (05) : 509 - 512
  • [48] Non-alcoholic fatty liver disease in polycystic ovarian syndrome in Indian women
    Siwatch, Sujata
    Singh, Virendra
    Dhaliwal, Lakhbir K.
    Kumari, Sunita
    Singh, Kartar
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2022, 42 (05) : 957 - 961
  • [49] Prevalence and risk factors for biopsy-proven non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in a prospective cohort of adult patients with gallstones
    Garcia-Monzon, Carmelo
    Vargas-Castrillon, Javier
    Luis Porrero, Jose
    Teresa Alonso, Maria
    Bonachia, Oscar
    Jose Castillo, Maria
    Marcos, Alberto
    Quiros, Esther
    Ramos, Beatriz
    Sanchez-Cabezudo, Carlos
    Villar, Sol
    Saez, Alicia
    Rodriguez de Cia, Javier
    del Pozo, Elvira
    Vega-Piris, Lorena
    Soto-Fernandez, Susana
    Lo Iacono, Oreste
    Eugenia Miquilena-Colina, Maria
    LIVER INTERNATIONAL, 2015, 35 (08) : 1983 - 1991
  • [50] Impact renaming non-alcoholic fatty liver disease to metabolic associated fatty liver disease in prevalence, characteristics and risk factors
    Huang, Xin-Juan
    Yin, Man
    Zhou, Bing-Qian
    Tan, Xin-Yun
    Xia, Yuan-Qin
    Qin, Chun-Xiang
    WORLD JOURNAL OF HEPATOLOGY, 2023, 15 (08) : 985 - 1000